Effects of Lidocaine Spray for Reducing Pain During Endometrial Aspiration Biopsy : a Randomized Controlled Trial
NCT ID: NCT03075358
Last Updated: 2018-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
240 participants
INTERVENTIONAL
2017-03-06
2018-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to examine the effect of lidocaine spray for reducing pain during the endometrial aspiration procedure by comparing it with placebo and no intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial
NCT01505920
Effect of Lidocaine Spray for Pain Relief During Endometrial Biopsy: a Randomized, Double-blind, Placebo-controlled Clinical Trial
NCT02039661
Effects of Cervical Lidocaine Spray on Pain Relief During Manual Vacuum Aspiration
NCT06344637
Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy
NCT03382743
10% Lidocaine Spray for Intrauterine Device Insertion
NCT03870711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lidocaine spray
Lidocaine spray
Patients are locally anesthetized with 8 puffs (80 mg, 10mg/puff, 0.8 ml) of 10% lidocaine spray applied thoroughly to the cervix, 3 minutes before starting the procedure.
Normal saline spray
Normal saline spray
0.8 ml of normal saline spray is applied to the cervix, 3 minutes before starting the procedure
No spray
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine spray
Patients are locally anesthetized with 8 puffs (80 mg, 10mg/puff, 0.8 ml) of 10% lidocaine spray applied thoroughly to the cervix, 3 minutes before starting the procedure.
Normal saline spray
0.8 ml of normal saline spray is applied to the cervix, 3 minutes before starting the procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Previous uterine or cervical surgical procedures
* Neurological abnormalities
* Coagulopathy
* Infection of cervix, vagina, or pelvic cavity
* Taking any analgesic drugs within 4 hours before the procedure
20 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chiang Mai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kittipat Charoenkwan, MD
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kittipat Charoenkwan, MD, MSc
Role: STUDY_CHAIR
Faculty of Medicine, Chiang Mai University
Ratpaporn Piyawetchakarn, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine, Chiang Mai University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of OB-GYN, Faculty of Medicine, Chiang Mai University
Chiang Mai, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OBG-2559-04137
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.